Study Stopped
Covid-2019
Longitudinal Observational Study in Prematurely Born Preschool Children: Assessment of Lung Function Parameters
1 other identifier
observational
152
1 country
1
Brief Summary
The PRE-AR project is a longitudinal observational study. The primary objective is the assessment of lung function parameters in late preterm preschool children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2015
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2015
CompletedFirst Submitted
Initial submission to the registry
October 2, 2015
CompletedFirst Posted
Study publicly available on registry
December 22, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2020
CompletedApril 14, 2026
April 1, 2026
4.9 years
October 2, 2015
April 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Forced oscillation technique
Longitudinal assessment of forced oscillation technique (FOT)
Baseline, 24 months, and 48 months
Spirometry
Longitudinal assessment of spirometry
Baseline, 24 months, and 48 months
Interrupter resistance
Longitudinal assessment of interrupter resistance (RINT)
Baseline, 24 months, and 48 months
Secondary Outcomes (5)
Nasal nitric oxide
Baseline, 24 months, and 48 months
Atopy
Baseline
Nasal brushing
Baseline
Saliva sample
24 months, and 48 months
Urine analysis
Baseline, 24 months, and 48 months
Study Arms (2)
59 prematurely born children
Lung function assessment of 59 prematurely born children (of both sex and 3-5 years old) attending as outpatient clinic of Pediatric Allergology \& Pulmonology (PAP) of Respiratory Disease Research Center (RDRC) within the Institute of Biomedicine and Molecular Immunology (IBIM) of the National Research Council (CNR) of Palermo (RDRC-IBIM CNR)
93 full-term born children
Lung function assessment of a Control group of full-term born children (N=93), recruited by a collaborative Pediatricians network within the Institute of Biomedicine and Molecular Immunology (IBIM) of the National Research Council (CNR) of Palermo (RDRC-IBIM CNR), Italy.
Interventions
Lung Function Assessment
Eligibility Criteria
A study population of 59 prematurely born children (of both sex and 3-5 years old) attending as outpatient clinic of Pediatric Allergology \& Pulmonology (PAP) of Respiratory Disease Research Center (RDRC) within the Institute of Biomedicine and Molecular Immunology (IBIM) of the National Research Council (CNR) of Palermo (RDRC-IBIM CNR). A Control group of full-term born children (N=93), recruited by a collaborative Pediatricians network within the Institute of Biomedicine and Molecular Immunology (IBIM) of the National Research Council (CNR) of Palermo (RDRC-IBIM CNR), Italy. The subjects will be paired up according to the sex and to the age, with a ratio 1:1.
You may qualify if:
- Premature birth \< 37 weeks
- years old ≤ Age ≥ 3 years old
- Control group
- Full-term birth
- years old ≤ Age ≥ 3 years old
You may not qualify if:
- Pulmonary bronchodysplasia (BDP)
- Acute respiratory infection
- Immunological and metabolic system disease
- Malformation of upper respiratory tract
- Topical or systemic therapies, with antibiotics, antihistaminics and corticosteroids, in the previous 30 days
- Patients with neurological pathologies
- Patients that are not able to perform the lung function tests
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Biomedicine and Molecular Immunology, IBIM
Palermo, Palermo, 90146, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Stefania La Grutta, MD. Senior Researcher. Coordinator of Pediatric Allergy and Asthma Research Group. Institute of Biomedicine and Molecular Immunology, IBIM, National Research Council of Palermo, Italy.
Study Record Dates
First Submitted
October 2, 2015
First Posted
December 22, 2015
Study Start
March 1, 2015
Primary Completion
February 1, 2020
Study Completion
February 1, 2020
Last Updated
April 14, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
The IPD collected will be available on december 2023. The following participant data will be shared: * Pulmonary function tests * Demographic characteristics All IPD will be obtained from statistical analysis on the dedicated database in which all data are stored.